Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05124808 · ClinicalTrials.gov registry record · NA
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
A NA study of Overweight and Obesity and Gestational Diabetes, sponsored by Indiana University.
- Recruiting
- Registry status
- NA
- Development phase
- 828
- Enrollment target
- 5
- Study locations
NCT05124808: Recruiting NA study of Overweight and Obesity and Gestational Diabetes, sponsored by Indiana University.
NCT05124808 is a NA study of Overweight and Obesity and Gestational Diabetes that is actively recruiting participants, run by Indiana University. The registered enrollment target is 828 participants, above the 221-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (275% higher). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05124808, a NA study of Overweight and Obesity and Gestational Diabetes, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- NA
- Development phase
- 828 participants
- Enrollment target
- 5
- Study locations
Study Summary
This is a multicenter randomized clinical trial of 828 overweight and obese individuals with gestational diabetes designed to compare standard to intensive glycemic targets.
Primary Outcome
Composite of large for gestational age birth weight, neonatal hypoglycemia, neonatal jaundice, and neonatal respiratory distress syndrome
Conditions Studied
Interventions
- OTHER Intensive glycemic targets
- OTHER Standard glycemic targets
Study Locations (5)
Alabama
- University of Alabama at Birmingham - Birmingham
Indiana
- Indiana University - Indianapolis
Oklahoma
- University of Oklahoma - Norman
Pennsylvania
- University of Pittsburgh - Pittsburgh
Rhode Island
- Women and Infants Hospital of Rhode Island - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 828 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2026-04-08 |
| Phase | NA |
What NCT05124808 shows while recruiting
NCT05124808 is an interventional study that assigns participants to a tested intervention. The registered 828 participants enrollment target is mid-sized for trials with a published cap, above the 221-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (275% higher).
The record links to 3 conditions, with Overweight and Obesity appearing as the primary indexed condition, and to 2 interventions - of which Intensive glycemic targets is the first listed.
NCT05124808 lists 5 locations in 5 states (Alabama, Indiana, Oklahoma).
Frequently Asked Questions
What is clinical trial NCT05124808 about?
NCT05124808 is a clinical study titled "Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes". This is a multicenter randomized clinical trial of 828 overweight and obese individuals with gestational diabetes designed to compare standard to intensive glycemic targets.
What is the current status of trial NCT05124808?
This trial is currently recruiting. It is a NA study. The enrollment target is 828 participants. The study started on 2022-03-01. Estimated completion is 2026-04-08.
What conditions does trial NCT05124808 study?
This clinical trial studies the following conditions: Overweight and Obesity, Gestational Diabetes, Pregnancy, High Risk.
What interventions are being tested in trial NCT05124808?
The interventions under investigation include: Intensive glycemic targets (OTHER), Standard glycemic targets (OTHER).
Who is sponsoring clinical trial NCT05124808?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05124808 being conducted?
This trial has 5 study locations across Alabama, Indiana, Oklahoma, Pennsylvania, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overweight and Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05124808's enrollment target sits among peer trials
828 6th of 115 higher than 110 of 115 other Overweight and Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overweight and Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dose Response Effects of Pecan Consumption
RECRUITING · NA
-
A Pilot Factorial Trial of an Integrated Lifestyle Intervention
RECRUITING · NA
-
Cottonseed Oil Dose Response
RECRUITING · NA
-
Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities
RECRUITING · NA
-
Testing the Adipose Expandability Hypothesis in Vivo During Overfeeding
RECRUITING · NA
-
Cottonseed Oil Versus Matched PUFA Effects
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03547973 · 827 participants · Phase 2
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
- NCT05067283 · 830 participants · Phase 1
A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
- NCT06592924 · 830 participants · Phase 3
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- NCT06868277 · 830 participants · Phase 3
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI